Trial intelligence / Profile preview

TAP Block vs PCA in Cesarean Section

NCT04405336Completed

Sponsor
Al Jazeera Hospital
Start
May 2020
Primary completion
Mar 2021
Modality
Small Molecules
Countries
1
01

Overview

Randomised, open-label trial of bupivacaine in postoperative pain (3 arms), sponsored by Al Jazeera Hospital. Primary endpoint: The number of women who will feel less pain post CS at 2 days. Started May 2020; status: completed.

02

Drugs

bupivacaine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT04405336.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04405336.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call